Should I buy National Health Investors, Inc. (NHI) stock or is it too late?
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
Firm-by-firm track record on National Health Investors, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| BMO Capital | 33 % | -2.4 % | 6 | $80 +22% |
| Keybanc | 20 % | -19.8 % | 5 | $88 +34% |
✅ Reasons to believe
- 60% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
- Median price target $80, i.e. +22% from the current price ($66).
- The most reliable firm on NHI, Wells Fargo (100% hit rate, 2 scored calls), targets $78 (call made on September 1, 2026, maturing on September 1, 2027) (+19%) in its most recent call, and $85 (call made on November 25, 2025, maturing on November 25, 2026) (+30%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 5 ratings, 2 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on NHI
Median target $80 (+22%) · 5 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in National Health Investors, Inc. now?
We won't decide for you. The facts: 60% of analysts rate it a buy, median target $80 (+22%), and Wells Fargo (most reliable on NHI, 100%) targets $78. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in National Health Investors, Inc.?
Not according to analysts: the median target ($80) is still +22% above the current price ($66) (most reliable on NHI: Wells Fargo, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is National Health Investors, Inc. still worth investing in?
It depends on the gap between the price ($66) and its estimated value: analysts target $80 on median (+22%), with 60% buys (most reliable on NHI: Wells Fargo, 100%). Cross-check with their real reliability on NHI and the cautions above. Information, not advice.
What's the main risk in buying NHI?
The consensus is not unanimous: of 5 ratings, 2 are neutral.
→ Go deeper: the full National Health Investors, Inc. profile (consensus, analyst reliability, price target, performance).